Mindfulness-Based Therapy for Chronic Lower Back Pain
(IMPACT Trial)
Trial Summary
What is the purpose of this trial?
This study will identify unique signatures that people have which can cause pain by evaluating biological, psychological, and social markers using artificial intelligence. These markers can be used to accurately predict the response of diverse individuals with chronic low back pain (cLBP) to Mindfulness-Based Stress Reduction. This will help enhance clinician decision-making and the targeted treatment of chronic pain. The overall objective is to use a unique machine learning (ML) approach to determine the biomarker signature of persons undergoing mindfulness based stress reduction (MBSR) treatment for their chronic low back pain (cLBP). This signature will facilitate clinical prediction and monitoring of patient response to MBSR treatment. The design of the study is a single-arm clinical trial of the evidence-based MBSR program for patients with cLBP.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Mindfulness-Based Stress Reduction (MBSR) for chronic lower back pain?
Is Mindfulness-Based Stress Reduction (MBSR) safe for humans?
How is Mindfulness-Based Stress Reduction (MBSR) different from other treatments for chronic lower back pain?
Mindfulness-Based Stress Reduction (MBSR) is unique because it is a non-drug treatment that focuses on mindfulness meditation to help manage chronic lower back pain, potentially reducing the need for medication. It is an eight-week group program that emphasizes mental awareness and stress reduction, which can improve pain management and quality of life.14568
Research Team
Natalia Morone, MD MS
Principal Investigator
Boston Medical Center
Jean King, PhD
Principal Investigator
Worcester Polytechnic Institute
Emmanuel Agu, PhD
Principal Investigator
Worcester Polytechnic Institute
Eligibility Criteria
This trial is for English-speaking individuals who have had chronic low back pain for at least 3 months, with pain on most days in the past 6 months. Participants must be able to consent and plan to stay at a participating clinic for over 6 months. It's not suitable for those with recent severe symptoms, unexplained weight loss or fever, pregnant women, or people with metastatic cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
UG3 Phase
Machine learning modeling to identify candidate predictive and monitoring markers of cLBP response to MBSR, with recruitment and outcomes assessment with 50 persons
UH3 Phase
Biopsychosocial markers identified for cLBP response to MBSR, with data collection for training and testing ML models
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Mindfulness-Based Stress Reduction
Mindfulness-Based Stress Reduction is already approved in United States, European Union for the following indications:
- Chronic Low Back Pain
- Chronic Pain Management
- Stress Reduction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Medical Center
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Worcester Polytechnic Institute
Collaborator